Great Point Partners’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Great Point Partners’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-437,865	Closed	-$15.9M	–	52
2016 Q4	$15.9M	Buy	437,865 +37,865	+9%	+$1.34M	3.27%	15
2016 Q3	$15.3M	Buy	+400,000	New	+$5.91M	3.89%	12

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Great Point Partners's CLCD Position: Q1 2017 in Review

Great Point Partners sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 437,865 shares — an estimated $15.9M sold.

Great Point Partners first reported a position in CLCD in Q3 2016 and held it in 2 quarters. The position peaked at $15.9M in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

Great Point Partners reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Great Point Partners sold 437,865 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $15.9M.
Great Point Partners first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
Great Point Partners's CoLucid Pharmaceuticals, Inc. position peaked at $15.9M in Q4 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Great Point Partners's 13F filing for Q1 2017, filed 15 May 2017.